Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolerability of Different Sarilumab Formulations in Healthy Men
NCT06159452Phase 1Completed
- Sponsor
- Sanofi
- Start
- Jul 2010
- Primary completion
- Dec 2010
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
01
Overview
Phase 1, randomised, double-blind trial of sarilumab in rheumatoid arthritis (RA) (7 arms), sponsored by Sanofi. Primary endpoint: Number of participants reporting injection site reactions at Day 35. Started Jul 2010; status: completed.
02
Drugs
sarilumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT06159452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06159452.